• Cardea Bio Adds $6.5 Million to Series A; Early-Stage Financing Now Totals More Than $20 Million

    3 days ago - By San Diego Biotechnology

    SAN DIEGO--Cardea Bio, Inc., a Tech+Bio company integrating molecular biology with semiconductors via Graphene-based biology-gated Transistors, announced today a $6.5M series A extension that brings the A round total above $20M. The ne......
    Read more ...